AbbVie Submits Anti-Inflammatory Drug Rinvoq for FDA, Europe Approval for Atopic Dermatitis

AbbVie Submits Anti-Inflammatory Drug Rinvoq for FDA, Europe Approval for Atopic Dermatitis

Already given the green light for rheumatoid arthritis, the drug could soon be prescribed for a common skin ailment.

Read More…

You May Also Like